Ostene in Thoracolumbar Decompression and Fusion Evaluated with VIBE
Launched by UNIVERSITY OF MARYLAND, BALTIMORE · Jun 4, 2024
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
* Patients will be screened prior to surgery for inclusion and exclusion criteria.
* If eligible, patients will be approached in the preoperative area or clinic location to consent or refuse participation in the study.
* Baseline characteristics will be collected via a combination of patient preoperative survey and manual chart review.
* Patients will undergo the normal surgical standard of care, receiving Ostene intraoperatively as determined appropriate by the attending spine surgeon during the procedure.
* It is anticipated that Ostene will be used specifically during the bony work/lamin...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients 18 to 88 years old
- • Elective thoracolumbar decompression, instrumentation, and fusion procedure
- • Open, posterior approach
- • Patients included for analysis in a related prior study which had enrollment criteria congruent with the current study
- Exclusion Criteria:
- • Indication for trauma, tumor, or suspected/confirmed infection
- • Emergent triage status
- • Anterior or lateral approach
- • Minimally invasive approach
About University Of Maryland, Baltimore
The University of Maryland, Baltimore (UMB) is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, UMB leverages its extensive resources and expertise across various disciplines, including medicine, pharmacy, nursing, and social work, to contribute to groundbreaking discoveries and improve patient outcomes. Committed to ethical research practices and collaboration, UMB fosters an environment that promotes the translation of scientific knowledge into real-world applications, ultimately enhancing the well-being of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported